Sort by
Refine Your Search
-
- 221AD305 Phase IIIb/IV, randomized, double-blind, placebo-controlled, parallel-group study to verify the clinical benefit of aducanumab in participants with Alzheimer's disease. Duration of the contract
Enter an email to receive alerts for parallel "EURAXESS" positions